Sigachi Industries unveils new products PureCoat and UltraMod
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
Subscribe To Our Newsletter & Stay Updated